Andera Partners

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors

Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences

Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upcoming Clinical Milestones

Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca

Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom

Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC Pipeline